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In Brief
Thiele et al. show that importin-a3 is one
of the major nuclear transporters of NF-
kB in the mammalian lung. High-level
TNF-a-inducing HPAIVs inhibit importin-
a3 mRNA transcription by interfering with
its promoter activity. Thus, HPAIVs may
evade antiviral immunity in the respiratory
tract by generating a bottleneck in
importin-a3 availability.
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Importin-a adaptor proteins orchestrate dynamic nu-
clear transport processes involved in cellular homeo-
stasis. Here, we show that importin-a3, one of the
main NF-kB transporters, is the most abundantly ex-
pressed classical nuclear transport factor in the
mammalian respiratory tract. Importin-a3 promoter
activity is regulated by TNF-a-induced NF-kB in a
concentration-dependent manner. High-level TNF-
a-inducing highly pathogenic avian influenza A vi-
ruses (HPAIVs) isolated from fatal human cases
harboring human-type polymerase signatures (PB2
627K, 701N) significantly downregulate importin-a3
mRNA expression in primary lung cells. Importin-a3
depletion is restored upon back-mutating the HPAIV
polymerase into an avian-type signature (PB2 627E,
701D) that can no longer induce high TNF-a levels.
Importin-a3-deficient mice show reduced NF-kB-
activated antiviral gene expression and increased
influenza lethality. Thus, importin-a3 plays a key
role in antiviral immunity against influenza. Lifting
the bottleneck in importin-a3 availability in the lung
might provide a new strategy to combat respiratory
virus infections.
INTRODUCTION
Molecular trafficking of proteins between the cytoplasm and the
nucleus is a fundamental process that is essential to maintainThis is an open access article under the CC BY-Ncellular homeostasis (Go¨rlich and Mattaj, 1996; Imamoto et al.,
1995). Disturbances in these highly sensitive regulatory pro-
cesses may result in the disequilibrium of cellular and nuclear
proteins and eventually cause diseases. Importin-a proteins
belong to the major nuclear transport factors in the cell shuttling
various cargo proteins containing a nuclear localization signal
(NLS) from the cytoplasm to the nucleus (Goldfarb et al., 2004).
Importin-a proteins are acidophilic proteins that bind as adap-
tors to cargo proteins containing a basic stretch of mono- or
bipartite NLS motifs. This importin-a/cargo complex forms a
trimeric complex with the receptor protein importin-b1, which
finally translocates through the nuclear pore by the interaction
of importin-b1 with nucleoporins (Hu et al., 1996; Radu et al.,
1995; Rexach and Blobel, 1995). In the nucleus, the guanosine
triphosphate (GTP)-bound form of Ran binds to importin-b1
and mediates the dissociation and release of the cargo protein
into the nucleus (Lee et al., 2005; Matsuura and Stewart,
2005). After successful nuclear import, importin-a binds to the
recycling factor cellular apoptosis susceptibility protein (CAS)
that, in conjunction with RanGTP, transports the complex back
into the cytoplasmwhere importin-a is again available for the nu-
clear import of other cargo proteins (Kutay et al., 1997). Importin-
a proteins are highly conserved throughout evolution (Goldfarb
et al., 2004). In eukaryotes, seven importin-a isoforms were
described, whereas the budding yeast encodes one importin-
a, and flies and nematodes encode for three importin-a isoforms.
However, all of these organisms encode for only one importin-b1
receptor protein. The specificity of importin-a isoforms to cargo
proteins is determined by the complexity and the three-dimen-
sional context (Friedrich et al., 2006; Goldfarb et al., 2004; Sank-
hala et al., 2017). Moreover, importin-a proteins play a key role in
cellular differentiation by regulating the transport of transcriptionCell Reports 31, 107549, April 21, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
factors through lineage-specific expression profiles in cells (Ya-
suhara et al., 2007). However, little is known about the expres-
sion profiles of importin-a isoforms in organs that could give
important insights into molecular mechanisms in health and dis-
ease. There is accumulating evidence that under cellular stress,
such as oxidative stress, heat shock, or ultraviolet irradiation, im-
portin-a proteins may accumulate in the nucleus and disrupt
cellular homeostasis (Furuta et al., 2004; Kodiha et al., 2004; Ya-
suda et al., 2012). In the last decade, a growing amount of evi-
dence suggests that importin-a proteins are utilized by various
viruses (e.g., influenza, Ebola, dengue, hepatitis C, and corona-
viruses) to circumvent host defense mechanisms (Basler and
Amarasinghe, 2009; Canton et al., 2018; Fraser et al., 2014; Frie-
man et al., 2007; Gabriel et al., 2011; Hudjetz and Gabriel, 2012;
Kopecky-Bromberg et al., 2007; Neufeldt et al., 2013; Pryor
et al., 2007). Little evidence is available on their mode of action
in specific organs under inflammatory conditions such as virus
infections. In this study, we identified the anatomic expression
profile of importin-a isoforms in the mammalian lung and studied
their transcriptional regulation and impact on influenza-virus-
induced pneumonia using cell culture models, genome-wide
transcription analyses, and transgenic mouse models.
RESULTS
Importin-a3 Is theMost Abundantly Expressed Importin-
a Isoform in the Mammalian Respiratory Tract
In order to analyze the expression pattern of major importin-a
isoforms throughout the mammalian respiratory tract (RT), we
anatomically dissected the human and murine RT into an upper
part defined by respiratory cells of the nasal concha (URT) and a
lower part defined by bronchi and alveoli (LRT). Importin-a1, -a3,
and -a5/7 isoforms (Kpna2, Kpna4, and Kpna1/6, respectively)
were abundantly expressed in epithelial cells, glands, and mac-
rophages of the human (Figure 1A) aswell as themurine URT and
LRT (Figure 1B). We then measured the relative mRNA expres-
sion levels of importin-a isoforms along the mammalian RT. In
the human URT and LRT, importin-a3 was by far the most abun-
dantly expressed isoform, with 4–5 times increasedmRNA levels
compared to importin-a1. Average expression levels of other
isoforms were similar to those of importin-a1, except for impor-
tin-a7, which was the second-most abundant isoform (Fig-
ure 1C). Similarly, importin-a3 was also the highest-expressed
isoform, followed by importin-a7 in the murine URT and LRT.
Laser-based microdissection of epithelial cells was used to
ensure homogeneous cell populations (Figure 1D). We further
confirmed the exclusive abundance of importin-a3 in the murine
lung, followed by importin-a7 as the second-most abundant iso-
form also on the protein level, using whole-organ homogenates
(Figures 1E and 1F). Notably, in immortalized cells (Figures
S1A–S1D) and unlike in primary cells, importin-a1 is the most
abundant isoform and is therefore used as a prognostic cancer
marker (Christiansen and Dyrskjøt, 2013; Dahl et al., 2006; Kau
et al., 2004). Thus, it is particularly important to investigate the
role of importin-a isoforms either in primary cells or in an in vivo
animal model. We then determined the expression of importin-a
isoforms in various murine organs on the mRNA and protein
levels and confirmed that the lung (Figure S1E) is unique in exhib-2 Cell Reports 31, 107549, April 21, 2020iting exclusively high importin-a3 levels, compared to other solid
organs (Figures S1F–S1K). Moreover, comparable distribution
and expression levels of importin-a isoforms within the human
and murine RT suggest that the mouse model may be consid-
ered adequate to study the impact and mode-of-action of these
cellular factors in health and disease. Next, we directly
compared relative importin-a amounts in laser-microdissected
epithelial samples of the URT versus the LRT (Figures 1G–1K).
For all importin-a isoforms,mRNA levels were highest in the alve-
olar tissue (LRT (A), up to 6 times) followed by epithelial cells of
the bronchi and bronchioles (LRT [bronchiolar epithelium, BE]).
The lowest mRNA levels were detected in epithelial cells of the
nasal concha (URT). Thus, importin-a isoforms are expressed
as a gradient in the RT with gradually increasing mRNA levels
from the URT toward the LRT (Figure 1L). However, importin-
a3 is the most abundantly expressed importin-a isoform in the
mammalian RT, unlike in other solid organs.
Importin-a3 Mediates Nuclear Translocation of TNF-
a-Activated NF-kB
NF-kB subunits (p50, p65) are translocated into the nucleus in an
importin-a-mediated manner. Herein, particularly importin-a3
and its close relative, importin-a4, were shown to act as one of
the main isoforms that imports tumor necrosis factor alpha
(TNF-a)-activated p50/p65 heterodimers into the nucleus via
direct interaction (Fagerlund et al., 2005). Since the mammalian
lung most abundantly expresses the importin-a3 isoform, we
continued to dissect the physical and functional interaction be-
tween importin-a3 and NF-kB. We could confirm that purified
human importin-a3 protein directly interacts with NF-kB p50
and p65 subunits as well as with its precursor p105 protein
upon activation with TNF-a unlike importin-a1 that was used
as a negative control (Figures 2A and 2B). Consistently, treat-
ment of murine fibroblasts with TNF-a most significantly
increased NF-kB levels in nuclear cell fractions along with impor-
tin-a3 (Figure 2C). In order to confirm that importin-a3 is
required for the nuclear import of NF-kB, we generated murine
embryo fibroblasts (MEFs) with a deleted importin-a3 gene
(a3/). Nuclear fractionation analysis in TNF-a-treated a3/
MEFs showed significantly reduced nuclear translocation of
the NF-kB subunit p65 compared to wild-type (WT) control
(a3+/+) MEFs (Figure 2D). Immunofluorescence analysis further
confirmed that nuclear localization of NF-kB p65 was also
reduced in a3/ MEFs compared to a3+/+ MEFs (Figure 2E).
Conversely, NF-kB p65 accumulated in the cytoplasm of a3/
MEFs, albeit slightly, likely due to the degradation of inefficiently
transported cargo proteins (Figure 2E). The extent of reduced
nuclear localization of importin-a3 was dependent on the
method used, albeit the absence of importin-a3 consistently
impaired efficient nuclear localization of TNF-a-induced NF-kB
subunit p65. These data clearly show that importin-a3 acts as
a nuclear translocator of TNF-a-activated NF-kB.
Importin-a3 Promoter Activity Is Regulated
by TNF-a-Activated NF-kB
We further observed an increase in general importin-a3 protein
levels upon TNF-a treatment in total cell lysates, including nu-
clear and cytoplasmic cell fractions of murine as well as primary
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Figure 1. Importin-a Expression in the Mammalian Respiratory Tract
(A and B) Importin-a1, -a3, or -a5/7 proteins were stained (red) in human (A) or murine (B) upper (URT, nasal epithelial cells) and lower respiratory tract (LRT,
bronchi and alveoli) sections by IHC-P (immunohistochemistry-paraffin protocol) and counterstained with hematoxylin. The importin-a7 antibody cross-reacts
with importin-a5. 4003 (URT and bronchi in A) or 10003 (alveoli in A and B) original magnification. Scale bar, 10 mm.
(C and D) Importin-amRNA levels in the human (C) and murine (D) URT and LRT determined by qRT-PCR. Relative importin-a1 expression values were set to 1
after normalization against GAPDH (Glycerinaldehyd-3-phosphat-dehydrogenase). Each data point represents an individual sample (n = 6–12).
(E and F) Importin-a protein amounts in murine LRT. Western blot analyses using importin-a isoform-specific antibodies and GAPDH adjustment were performed
to determine endogenous importin-a protein amounts (a1, a3, a5, a7) in murine organs. For relative quantification (E), standard curves of affinity-purified, FLAG-
tagged importin-a proteins were used. Relative importin-a1 protein amount in murine LRT was set to 1. Data shown represent means ± SD (n = 3 biological
replicates; technical replicates: n = 1–2 per organ, n = 1–2 western blot analyses). Representative western blots for the endogenous importin-a isoforms and the
standard curves are shown in (F). The gaps in (F) depict cropping of the relevant bands run on the same gel.
(G–K) Comparison of importin-a mRNA expression levels between murine URT and LRT: a1 (G), a3 (H), a4 (I), a5 (J), or a7 (K). A, alveoli; BE, bronchiolar
epithelium; n = 8–12.
(L) Schematic partition of the RT with increasing importin-a mRNA levels from URT to LRT.
*p < 0.05; **p < 0.01; ***p < 0.001.
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airway epithelial cells (Figures 2F and 2G). These findings might
suggest that importin-a3 gene expression itself could also be
affected by TNF-a treatment. In order to understand how impor-
tin-a3 gene transcription is regulated, we screened the promoter
region of the importin-a3 gene for the presence of potential tran-
scription factor binding sites. We found that the promoter region
of the importin-a3 gene contains a binding site for NF-kB, as
shown by earlier chromatin immunoprecipitation studies (Raska-
tov et al., 2012) (Figure 2H). Consistently, using a reporter
construct encoding for renilla luciferase under the control of
the importin-a3 promoter, we could show that importin-a3
gene expression is differentially affected upon TNF-a treatment
in a cell-type- and dose-dependent manner (Figures 2I–2K). In
clinically relevant primary human airway epithelial cells as well
as in generated MEFs herein, importin-a3 promoter activity
was highest upon low-dose TNF-a treatment, while high-dose
TNF-a treatment resulted in a reduction of importin-a3 gene
expression (Figures 2J and 2K). However, multi-passage
cancerous A549 cells presented high resistance to TNF-a treat-
ment (Figure 2I), suggesting a delayed dose-response curve.
Treating MEFs with other cytokines, such as interleukin (IL)-10
or transforming growth factor b (TGF-b) did not significantly alter
importin-a3 promoter activity, unlike TNF-a treatment (Figures
S2A and S2B), albeit IL-10 presented a slight induction (Fig-
ure S2A). Next, we wanted to assess whether TNF-a-activated
NF-kB is directly involved in regulating importin-a3 gene tran-
scription. Therefore, we used cells deficient in the NF-kB essen-
tial modulator (NEMO), the regulatory subunit of the IKK (IkB ki-
nase), which is required for NF-kB phosphorylation and thus its
activation. Importin-a3 mRNA levels were reduced in TNF-
a-treated NEMO/ cells compared to untreated controls (Fig-
ure 2L). As expected, reduced importin-a3 mRNA levels also re-
sulted in reduced importin-a3 protein expression in NEMO/
cells treated with TNF-a as compared to untreated cells (Fig-
ure 2M). Reduced importin-a3 expression in NEMO/ cells
could be restored upon transfection of a NEMO-expressing
plasmid back into NEMO/ cells (Figure 2M). Control treatmentFigure 2. Molecular Function and Regulation of Importin-a3
(A) Schematic overview of importin-a3-mediated NF-kB p65 nuclear translocatio
(B) Pull-down of NF-kB from lysates of untreated or TNF-a-treated A549 cells w
portin-a isoformswas verified with Coomassie staining (upper panel), and bound N
protein detection served as loading control. One representative experiment is sh
(C) Effect of TNF-a treatment on expression and localization of NF-kB p65 and i
(D and E) Nuclear fraction (NF; control p84) and cytoplasmic fraction (CF; control
after TNF-a treatment using cell fractionation assay (D) or immunofluorescence (
(F and G) After seeding, cells were serum starved for 24 h. Subsequently, cells wer
kB p65 protein levels were detected and quantified for whole-cell lysates (WCLs),
treated samples of each fraction were set to 100%.
(H) NF-kB binding sites in the promoter element of the human importin-a3 gene
(I–K) Effect of TNF-a treatment on importin-a3 promoter activity in HSAEpC (n = 2
promoter reporter construct (a3) transfection. Relative importin-a3 promoter act
(L) Importin-a3 mRNA levels in mock or TNF-a-treated MEF NEMO/ cells (n =
GAPDH, and importin-a1 mRNA expression was set to 1. Each data point repres
(M) MEF NEMO/ cells were transfected with empty plasmid (Mock) or NEMO
expression levels were detected (n = 3). GAPDH protein detection served as loa
(N) MEF NEMO/ cells were treated with 10 ng TNF-a, IL-6, IL-10, IFN-g and TG
(O) Importin-a3 gene expression is controlled by TNF-a-activated NF-kB in a dos
high expression of importin-a3 (upper panel). In contrast, high amounts of TNF-a in
Data shown represent means ± SD of at least three independent biological expeof NEMO/ cells with IL-6, IL-10, interferon (IFN)-g or TGF-b
showed similarly reduced importin-a3 mRNA expression levels
as upon TNF-a treatment (Figure 2N). It is important to note
that IL-6 transcription is directly dependent on NF-kB, unlike
IL-10, IFN-g or TGF-b. These findings support the concept that
TNF-a-activated NF-kB is crucial for importin-a3 gene expres-
sion. However, other cytokines might also reduce importin-a3
expression at high, but not low, cytokine concentrations (Fig-
ure S2C). Our findings support the concept that importin-a3
gene expression is controlled by TNF-a-activated NF-kB in a
cell- and dose-dependent manner. This is in line with general
control mechanisms in cells, such as negative or positive feed-
back loops, where gene transcription is regulated (e.g., either
by activating or blocking the promoter, respectively, depending
on demand) (Figure 2O). However, other, not yet defined, NF-kB-
independent pathways might also affect importin-a3 gene
expression. Future studies are required to dissect the importin-
a3 promotor for transcription factor binding sites other than
NF-kB.
High-Level TNF-a-Inducing Human-Type HPAIV
Infections Reduce Importin-a3 Protein Expression
Levels in Human Respiratory Cells
Since the NF-kB transporting nuclear import factor importin-a3
was the only isoform in the lung that altered its expression levels
upon TNF-a treatment, we wanted to know how importin-a3 is
regulated under respiratory stress associated with cellular cyto-
kine changes. Therefore, we used an influenza infection model.
We infected MEFs with highly pathogenic avian influenza A virus
(HPAIV) mutants that were known to act as low- or high-level
TNF-a inducers (Figure 3A). Then, we infected MEFs either
with the low-level TNF-a-inducing HPAIV containing an avian-
type polymerase signature (SC35-PB2701D), common in influ-
enza A virus (IAV) having a low replicative fitness in mammals,
or its high-level TNF-a-inducing HPAIV counterpart containing
a human-type polymerase signature (SC35M-PB2701N), com-
mon in IAV possessing a high replicative fitness and virulencen.
ith Sepharose-immobilized GST-importin-a1 and -a3. Expression of GST-im-
F-kBp105, p65, and p50were detected via western blot (lower panel). GAPDH
own out of three independent experiments.
mportin-a3 in WT MEFs (n = 3).
GAPDH) localization of NF-kB p65 in a3/MEFs or WT controls thereof (a3+/+)
E) as well as quantifications thereof (n = 3–5). Scale bar, 20 mm.
e control treated (w/o) or treated with TNF-a. Endogenous importin-a3 and NF-
CFs and NFs ofWTMEFs (n = 3) (F), andWCLs of HSAEpCs (n = 3) (G). Control-
in A549 cells (Raskatov et al., 2012).
) (I), MEFs (n = 3) (J), and A549 cells (n = 6) (K) upon control (Ctr) or importin-a3
ivity in control-treated samples was set to 100%.
6). Relative expression values of importin-a3 in samples were normalized to
ents an individual sample.
and untreated or treated with 50 ng TNF-a. Importin-a3 and NEMO protein
ding control.
F-b and importin-a3 mRNA levels were measured as described above (n = 3)
e-dependent manner. Low amounts of TNF-a induce activation of NF-kB and
duce high activation of NF-kB and low expression of importin-a3 (lower panel).
riments. *p < 0.05; **p < 0.01; ***p < 0.001.
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in mammalian species. Importin-a3 protein levels were strongly
reduced in human-type HPAIV compared to avian-type HPAIV-
infected MEFs (Figures 3B–3E). In contrast, protein expression
levels of other importin-a isoforms (a1, a4, a5, and a7) were
not affected (Figures 3F and 3G). Next, we wanted to assess
whether replication of avian- and human-type HPAIV is affected
in cells deficient in importin-a3. Cells deficient in importin-a3
were obtained from fibroblasts of mice generated for this study
with a deleted importin-a3 gene (a3/; a3/ MEFs; Figures
S2D and S2E). MEFs with a deficient importin-a7 gene were ob-
tained from mice with a deleted importin-a7 gene (a7/),
described previously (Gabriel et al., 2011). Replication kinetics
in MEFs revealed that avian-type but not human-type HPAIV
replication is impaired in cells with a deleted importin-a3 gene
(a3/), unlike in control cells, with a deleted importin-a7 gene
(a7/) that acts as a positive factor of human-type HPAIV repli-
cation in mammalian cells (Hudjetz and Gabriel, 2012) (Figures
3H and 3I). Interestingly, avian-type HPAIV replication in a3/
MEFs is increased by >1,000 times compared to WT control
cells. Human-type HPAIV replication was comparable between
WT and a3/ cells (Figures 3J and 3K). In line, human-type
SC35M-PB2701N HPAIV replication was not affected in human
H1299 a3+/+ cells upon TNF-a treatment, likely due to the strong
inhibition of importin-a3 protein expression (Figure 3L). In human
H1299 a3/ cells, SC35M-PB2701N HPAIV replication slightly
increased, suggesting some residual inhibitory activity of
importin-a3 in human cells (Figure 3L). These findings show
that low-level TNF-a-inducing HPAIVs with avian-type polymer-
ase signatures are highly sensitive to importin-a3-mediated virus
restriction. In contrast, high-level TNF-a-inducing HPAIVs with
human-type polymerase genes are resistant to importin-a3-
mediated virus restriction.
Importin-a3 Belongs to the Most Conserved Nuclear
Transport Factors between Avian and Mammalian
Species
Differential regulation of importin-a3 expression levels upon
avian- and human-type HPAIV infections prompted us to
analyze the sequence identity of importin-a isoforms in various
avian and mammalian species. Among all importin-a isoforms
analyzed, importin-a1 was the most diverse nuclear import fac-
tor, with amino acid homology of 83.52% between chicken and
humans (Figure 4A; Table S1). The isoforms importin-a3 and
importin-a4 displayed the highest amino acid homologies be-
tween chicken and humans of 99.04% and 98.08%, respec-Figure 3. HPAIV Replication Kinetics in Importin-a3/ Cells
(A) TNF-a induction in MEFs infected with avian-type SC35-PB2701D or human-t
(B–E) Protein extracts thereof were analyzed and quantified by western blot at 48 h
and E) with GAPDH (B and C) or NP adjustment (D and E) (n = 4). Dashed lines i
(F and G) Additionally, importin-a1, -a4, -a5, and -a7 and viral NP protein were de
were specific for importin-a3. Control-treated, uninfected samples or SC35-PB2
bodies with NP resulted in a band (#) in (B) and (F).
(H–K) Growth kinetics of avian-type SC35-PB2701D (H and I) and human-type SC
importin-a3/ (a3/, red), and importin-a7/ (a7/, green) MEFs were infecte
given in plaque-forming units (p.f.u.) were determined by plaque assay on MDCK
(L) H1299 a3+/+ (black) and a3/ (red) cells were infected with human-type SC
presence or absence of TNF-a (n = 3). Virus titers were determined by plaque as
importin-a amounts or logarithmic virus titers ± SD of at least three independenttively (Figures 4B and 4C; Table S1). Importin-a5, -a6, and
-a7 presented amino acid homologies between chicken and
humans of 95.91%, 94.22%, and 94.4%, respectively (Figures
4D–4F; Table S1). These findings suggest that particularly im-
portin-a3 and importin-a4, both known nuclear transporters
of NF-kB (Fagerlund et al., 2005), are highly conserved across
species kingdoms. However, importin-a3 is expressed up to
~5-times-higher levels than importin-a4 in the murine and
human lung (Figures 1C and 1D), highlighting particularly
the importance of importin-a3 in respiratory immune re-
sponses. Thus, acquiring the ability to downregulate importin-
a3 in the lung might serve as an important basis in avian-
mammalian virus transmission. In order to see whether
differential importin-a3 regulation is also present in human iso-
lates, we analyzed human-type HPAIV strains that caused
poultry outbreaks with human infections in the Netherlands
(H7N7) or Thailand (H5N1). Infection of primary lung cultures
with cytokine storm, including TNF-a-inducing H5N1 and
H7N7 HPAIV isolates with human-type polymerase signatures
(PB2627K; PB2701N), showed significantly reduced importin-a3
expression levels compared to their counterparts with avian-
type polymerase signatures (PB2627E; PB2701D) (Figures 4G
and 4H). These findings highlight the crucial role of importin-
a3 as a respiratory factor conserved across animal kingdoms
in HPAIV interspecies transmission.
Human-Type Polymerase Signatures in HPAIV Mediate
Reduced Importin-a3 mRNA Expression Levels in the
Murine BE
Next, we wanted to assess whether differential regulation of
importin-a3 can also be detected in a murine infection model.
Therefore, we assessed importin-a3 expression levels in lung
samples of HPAIV-infected WT mice. Infection with avian-type
SC35-PB2701D led to increased importin-a3 mRNA levels in the
lung compared to uninfected controls on day 3 post infection
(p.i.) (Figures 5A and 5B). In contrast, infection with human-
type SC35M-PB2701N resulted in significantly reduced impor-
tin-a3 mRNA levels (Figure 5C). Since the human-type SC35M
HPAIV contains mainly two host adaptive signatures (PB2
701N and NP 319K), we analyzed recombinant viruses with
these single mutations to dissect their individual impact on the
dysregulation of importin-a mRNA transcription. Herein, the
PB2 D701N host adaptive mutation was predominantly respon-
sible for reduced importin-a3 transcription, while its effect
was further enhanced when combined with the NP N319K hostype SC35M-PB2701N H7N7 HPAIV (MOI = 0.1) measured by ELISA (n = 3).
p.i. Importin-a3 and viral NP protein were detected (B and D) and quantified (C
n (D) depict cropping of the relevant bands run on the same gel.
tected and quantified with GAPDH adjustment to confirm that observed effects
701D-infected samples were set to 100%. Cross-reactivity of importin-a anti-
35M-PB2701N (J and K) H7N7 HPAIV in importin-a
/ MEFs (n = 3). WT (black),
d with low (H and J) or high (I and K) multiplicities of infection (MOI). Virus titers
II cells (0, 24, 48, 72, and 96 h p.i.).
35M-PB2701N HPAIV (MOI = 0.001) and replication kinetics measured in the
say on MDCKII cells (0, 24, 48 h p.i.). Data shown represent means of relative
biological experiments (*p ˂ 0.05; ***p < 0.001).
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Figure 4. High Importin-a3 Homology across Species and Its Role in HPAIV Interspecies Transmission from Birds to Humans
(A–F) Importin-a homologies across animal kingdoms. Homolgies for importin-a1 (A), -a3 (B), -a4 (C), -a5 (D), -a6 (E), and -a7 (F). Pairwise amino acid sequence
identities were calculated for importin-a across species.
(G and H) Primary human bronchial (HBEpC; G) or primary human small airway epithelial cells (HSAEpC; H) were infected with clinical fatal case A/Thailand/
1(KAN-1)/2004 (H5N1, MOI = 1) or A/Netherlands/219/2003 (H7N7, MOI = 10) isolates harboring the original human-type signatures (PB2701N or PB2627K,
respectively) or their recombinant avian-type counterparts (PB2701D or PB2627E, respectively). Importin-a3was quantified in NP-adjusted western blots of HBEpC
(H) and HSAEpC (I) infected with H5N1 (MOI = 0.1) or H7N7 (MOI = 1). Importin-a3/NP ratios of human-type virus infected samples at 24 h p.i. were set to 100%.
Data shown represent means ± SD of at least three independent biological experiments. *p < 0.05; **p < 0.01; ***p < 0.001.adaptive signature (Figures 5D–5F). Compared to all other im-
portin-a isoforms, importin-a3 continuously showed the most
prominent alterations. Interestingly, the most significant alter-
ations in importin-a3 mRNA levels were detected at 3 days p.i.
compared to 1 day p.i. (Figures S2F–S2K), consistent with the
concept that accumulating cytokine levels throughmultiple repli-
cation kinetics is required for a profound cytokine-dependent
repression of importin-a3 transcription. Avian-type SC35-
PB2701D virus replication, which caused an increase in impor-8 Cell Reports 31, 107549, April 21, 2020tin-a3 mRNA levels, was restricted to the respiratory tract (Fig-
ures S3A and S3B). In contrast, human-type SC35M-PB2701N
viral replication led to a significant reduction of importin-a3
mRNA levels in the lung, increased virus load in the lung, and
systemic virus spread (Figure S3C). The recombinant viruses
with the single or combined human-type PB2 701N and NP
319K signatures showed stepwise systemic spread along with
their ability to reduce importin-a3 mRNA levels in the lung (Fig-
ures S3D–S3F). These findings further highlight that host
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Figure 5. Importin-a3 Expression and Downregulation in Murine Lungs
(A–F) WT mice were control treated or infected with 63 104 p.f.u. of H7N7 recombinant viruses. Importin-amRNA expression levels (a1, a3, a4, a5, a7) on day 3
p.i. in lungs upon control treatment (A) or infection with SC35-PB2701D (B), SC35M-PB2701N (C), SC35-PB2701N (D), SC35-NP319K (E), or SC35-PB2701N-NP319K
(F) viruses. Relative importin-a1 expression values were set to 1 after normalization against GAPDH. Each data point represents an individual sample (n = 5,
*p < 0.05).
(G and H) Immunohistochemical staining of importin-a3 (G) and viral antigen (H) on day 3 p.i. in the LRT upon infection with H7N7 HPAIV. 4003 original
magnification. Scale bar, 10 mm. Immunohistochemical staining of virus antigen (red-brown) in theURT and LRT in a3/mice or theirWT litters a3+/+ infectedwith
6 3 104 p.f.u. of SC35-PB2701D or SC35M-PB2701N viruses on day 3 p.i. Control mice received PBS.adaptive signatures mediate impaired importin-a3 transcription,
resulting in high-level virus replication.
To determine the respiratory cell types, where reduction of im-
portin-a3 expression occurs, we stained serial lung sections for
importin-a3 as well as influenza virus antigen. Importin-a3 was
strongly expressed in the BE of avian-type SC35-PB2701D-in-
fected mice, correlating with reduced virus-antigen-positive
cells in these tissues compared to human-type SC35M-
PB2701N-infected animals (Figures 5G and 5H). In contrast, im-
portin-a3 protein levels in SC35M-PB2701N-infected mice were
predominantly reduced in the BE, which correlated with high-
level viral replication (Figures 5G and 5H). In line, virus replication
was increased in the lungs of a3/mice compared to their a3+/+
WT littermates infected either with SC35-PB2701D or SC35M-PB2701N virus (Figure S4). Thus, differential regulation of impor-
tin-a3 protein expression predominantly occurs in the BE, the
key site of productive influenza virus replication (Abdel-Ghafar
et al., 2008; Peiris et al., 2007).
Failure to Induce NF-kB-Controlled Antiviral Gene
Expression in the Lung Leads to Increased Mortality in
Importin-a3-Deficient Mice
Next, we addressed the question of whether reduction of pulmo-
nary importin-a3 levels would affect NF-kB-mediated antiviral
gene expression and whether this would affect disease
outcome. Therefore, we infected a3/ mice and their WT litter
mates (a3+/+) with avian- or human-type HPAIV. Lung transcrip-
tomics of mice infected with human-type SC35M-PB2701NCell Reports 31, 107549, April 21, 2020 9
ATNF-α
B
E
F
Re
lat
ive
 m
RN
A 
ex
pre
ss
ion
 le
ve
ls
(N
0 (
GO
I) / 
N 0
 (H
PR
T)
)
Control
G H SC35M-PB2701NSC35-PB2701D
0 2 4 6 8 10 12 14
0
20
40
60
80
100
Su
rvi
va
l [%
]
d p.i.
0 2 4 6 8 10 12 14
0
20
40
60
80
100
Su
rvi
va
l [%
]
d p.i.
Irf3Mavs
Tnfsf10Pik3ca
Tlr5Cd38
Cd8aCcr7
Cd4Cd83
Ifna14Ifnar1
Ifna6Ifna2
Il1bJak1
Tlr4Tlr8
Traf3Traf6
Cxcr4Ifng
Tlr1Tlr7
Jak2Tlr6
Cd86Nfkb2
Ifnar2Ccr5
Irf7Isg15
Cd40Tlr2
Ifit1Mx1
Ifnl3Oas1a
AdarIrf9
TnfIl15
Ccl4Ifit3
Oas2Stat2
Tlr9Irf1
Irf2Socs1
Ifna4Cd80
Ifi204Mx2
Il1r2Tlr3
Eif2ak2Ifi203
Casp3Casp4
Cxcl10Ifi205
FasPpp1ca
Lgals3Irak4
Il1r1Nfkb1
Ifna1Ifna5
Ifnb1Casp1
Ifnl2Pik3cg
Tyk2Foxp3
Ccl5Ifna13
Ifna7
Control
α3-/-
SC35M-
PB2701N
α3+/+ α3-/-α3+/+
0
500
1,000
1,500
Re
lat
ive
 TN
F-
α e
xp
res
sio
n [
%]
*
***
SC35-PB2701D SC35M-PB2701N
?3+/+
?3-/-
Re
lat
ive
 m
RN
A 
ex
pre
ss
ion
 le
ve
ls
(N
0 (
GO
I) / 
N 0
 (H
PR
T)
)
SC35M-PB2701N
?3+/+
?3-/-
?3 +/+
?3 -/-
_+/+
Control
?3
?3 -/-
_+/+
Control
?3
?3-/-
C
0
2
4
6
8
10
Re
lat
ive
 m
RN
A 
ex
pre
ss
ion
 le
ve
ls
(N
0 (
GO
I) / 
N 0
 (H
PR
T)
1 3
control
SC35-PB2701D
SC35M-PB2701N
TNF-α
* *
*
*
*
d p.i.
A1
A3
A4
A6
A5
A2
Control
α3-/- α3-/-
SC35-
PB2701D
SC35M-
PB2701N
1-1 0
Row Z-Score
- +
α3+/+ α3+/+α3-/-α3+/+
TN
FS
F-1
0
IFN
-ß1 IRF
-2
MX
-1 ?
IFN
-
EIF
2AK
2
IRF
-3
MA
VS
IFN
A-1
4
0.0
0.5
1.0
1.5
TN
FS
F-1
0
IFN
-ß1 IRF
-2
MX
-1 ?
IFN
-
EIF
2AK
2
IRF
-3
MA
VS
IFN
A-1
4
0.0
0.5
1.0
1.5
*****
D
Figure 6. Genes Responsive to HPAIV Infection in Lungs of WT and Importin-a3/ Mice
WT and importin-a3/ (a3/) mice were infected with SC35-PB2701D (H7N7) or SC35M-PB2701N (H7N7). Control mice received PBS.
(A) Heatmap depicting the row Z scores of the normalized expression values of 143 differentially expressed genes (p value% 0.01 and |log 2FC|R 1.5) that were
clustered according to their expression profiles in lungs on day 3 p.i.
(B) Heatmap depicting row Z scores of the normalized expression values of 79 genes with a previously described role in innate immunity (Engels et al., 2017).
(C) TNF-a expression levels detected by transcriptome analysis on day 3 p.i. in lungs of infected a3+/+ mice relative to themaximum expression observed. Control
was set to 100%.
(D) TNF-a protein levels measured by ELISA on day 1 p.i. in a3+/+ and a3/mice. Data show average results obtained from pooled lung samples of threeWTmice
per virus strain (*p < 0.05; ***p < 0.001).
(E and F) Relative mRNA-expression levels of antiviral genes under an NF-kB promoter determined by qRT-PCR 3 days p.i. in control (E) and infected lungs (F) of
a3+/+ and a3/ mice. Relative expression values of a3+/+ for each gene normalized to HPRT were set to 1. Data shown represent mean ± SD (n = 5; **p < 0.01;
***p < 0.001).
(G and H) Survival in a3+/+ and a3/mice infected with avian- (G) or human-type (H) H7N7 HPAIV. Data shown represent means ± SD (n = 9 for SC35 and n = 4 for
SC53M).
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HPAIV in WT as well as in a3/ mice revealed a subset of sub-
stantially altered expression patterns in genes involved in innate
immunity (Engels et al., 2017) (Figure 6A; Tables S2 and S3).
Herein, genes controlled by an NF-kB promoter were particularly
prominent, with 34%of all analyzed genes (27 out of 79 hits) (Fig-
ure 6B). Moreover, literature analysis of the hits highlighted that
especially genes involved in TNF pathways were of high abun-
dance, supporting the in vitro findings (data not shown). TNF-a
mRNA levels were increased in the lungs of human-type
HPAIV-infected a3+/+ mice when compared to lungs of avian-
type HPAIV-infected animals (Figure 6C). As expected, TNF-a
protein expression, which is also regulated by NF-kB, was
reduced in a3/ mice infected with both avian- and human-
type HPAIV (Figure 6D). We then assessed a subset of antiviral
genes under an NF-kB promoter that showed reduced expres-
sion in a3/ mice, such as TNFSF-10, IFN-b1, IRF-2, MX-1,
IFN-g, EIF2AK2 (alias PKR), IRF-3, MAVS, and IFNA-14. While
none of these genes showed significant alterations in PBS-
treated control mice irrespective of the presence or absence of
the importin-a3 gene (Figure 6E), the transcription, most promi-
nently of IRF-2 andMX-1 genes involved in major antiviral path-
ways, was most significantly reduced in SC35M-PB2701N
HPAIV-infected a3/ mice compared to a3+/+ mice (Figure 6F).
Infection of a3/ mice with both SC35-PB2701D and SC35M-
PB2701N resulted in enhanced weight loss and lethality
compared to a3+/+ mice (Figures 6G, 6H, and S5). Virulence
was significantly increased in human-type HPAIV-infected
a3/ mice (Table S4). These data show that importin-a3 is
required for the efficient expression of antiviral genes under the
control of an NF-kB promoter. Failure to induce these antiviral
pathways leads to high HPAIV virulence in mice.
DISCUSSION
Importin-a proteins serve as key proteins that regulate nucleo-
cytoplamic cargo protein transport to maintain cellular homeo-
stasis. Disruption of balanced transport pathways, caused under
stress or inflammatory conditions, can cause serious diseases.
In immortalized cancer cell lines, importin-a1 expression levels
are particularly high compared to non-cancerous cells, as shown
here as well as in many other studies before. Here, we shed light
on the anatomic distribution of importin-a isoforms in the
mammalian lung. We provide evidence of the highly abundant
expression of importin-a3 in the murine and human RT. More-
over, importin-a isoforms are expressed as a gradient, with
increasing concentrations from the URT to the LRT. Abundant
and exclusive high-level expression of importin-a3 was a hall-
mark of the lung, unlike in other solid organs assessed, such
as the liver, spleen, and brain. Knowledge on the importin-a
expression pattern in the lung is important to understand themo-
lecular basis of cellular homeostasis that might be dominated by
importin-a3-transported transcription factors.
According to the crystal structure of importin-a3, which was
recently solved, it was postulated that it is highly selective of
cargo proteins, unlike other importin-a isoforms (Pumroy et al.,
2015). The high substrate specificity is reflected by only a few
cargo proteins reported to be transported into the nucleus by im-
portin-a3. Importin-a3 seems to exclusively serve as a trans-porter of p53, a transcription factor involved in many cancer
pathways (Marchenko et al., 2010). Importin-a3 is also a key fac-
tor in the transport of the NF-kB subunits p50 and p65 into the
nucleus along with importin-a4, which is the closest relative of
importin-a3 (Fagerlund et al., 2005). Mutations in ARM3 of the
importin-a3 protein were shown to be crucial for p50 binding,
while mutations in ARM 7 and 8 were shown to be required for
p65 binding (Fagerlund et al., 2005). Based on the crystal struc-
ture of importin-a3, it was further postulated that it might pose a
‘‘fast track’’ nuclear import pathway under certain circum-
stances, such as environmental stress (e.g., viral infections),
where cellular amounts of importin-b1 may be limited, requiring
fast counteraction (Pumroy et al., 2015). This hypothesis is in
line with our findings in this study suggesting that importin-a3
serves as a defense mechanism against influenza by promoting
the nuclear entry of NF-kB, which controls the transcription of
many antiviral genes.
We further show that importin-a3 gene expression is highly dy-
namic under inflammatory conditions. We identified an NF-kB
binding site within the importin-a3 promoter element and show
that its transcription is dependent on TNF-a-activated NF-kB in
a concentration-dependent manner. HPAIVs that induce low-
level TNF-a expression, such as those with avian-type polymer-
ase signatures (PB2 627E and 701D), increase importin-a3
mRNA expression presumably by NF-kB induction. In contrast,
high-level TNF-a expression inducing HPAIV, such as those
harboring human-type polymerase signatures (PB2 627K and
701N), significantly reduces importin-a3 mRNA expression
levels by a yet-unknown mechanism. One possibility would be
that high numbers of NF-kB proteins may block the promoter
of the importin-a3 gene and thereby its transcription. Other
possible interferences could be with NF-kB-activating com-
plexes, such as NEMO or its repressor, IkBa. Future studies
are required to unravel the detailed mechanism underlying the
failure of importin-a3 promoter activation. Such diverse feed-
back loops are known in cellular processes, where gene tran-
scription depends on demand. Herein, generating a bottleneck
in importin-a3 availability leads to failure in inducing an adequate
antiviral immune response, as shown in mice lacking the impor-
tin-a3 gene. Interestingly, more than 30% of the differentially ex-
pressed genes between a3/ mice and their a3+/+ litter mates
were under the control of an NF-kB promoter, highlighting the
significant contribution of importin-a3 in NF-kB-mediated gene
transcription. We could further show, using HPAIV strains of
the H5N1 and H7N7 subtypes that have caused pneumonia
and death in humans, that downregulation of importin-a3
mRNA transcription was a hallmark that was mediated by their
human-type polymerase signatures. The introduction of avian-
type polymerase signatures into the genetic backbone of these
HPAIV outbreak strains restored importin-a3 mRNA transcrip-
tion in the lung. It is important to note that these human-type
HPAIVs induce a general cytokine storm, including TNF-a.
Thus, more detailed studies are required to understand the
impact of other cytokines on the transcription level of importin-
a3. However, a pulmonary increase in TNF-a levels with a
concomitant increase in virulence has been described for
many human H5N1 and H7N7 isolates containing human-type
(PB2627K) signatures (Abdel-Ghafar et al., 2008; de Jong et al.,Cell Reports 31, 107549, April 21, 2020 11
2006; Hatta et al., 2001; Peiris et al., 2007; Szretter et al., 2007).
Based on these findings, we propose that human-type HPAIVs
have evolved mechanisms within the mammalian host to evade
antiviral response pathways by high-level induction of TNF-
a-activated NF-kB, which blocks the transcription of importin-
a3, the major classical nuclear import protein expressed in the
mammalian lung.
We have shown previously that influenza A viruses utilize dif-
ferential importin-a isoforms to ensure replicative fitness (Gabriel
et al., 2011). Upon zoonotic transmission of HPAIV from birds to
humans, they switch from importin-a3 to importin-a7 usage.
While importin-a3 acts as an inhibitor of influenza virus polymer-
ase, importin-a7 acts as a positive factor of influenza virus repli-
cation. Importin-a7 is believed to act in a transport-independent
function by a yet-unknown mechanism. Until now, it was unclear
how importin-a3mediates antiviral activity. To unravel themech-
anism underlying the importin-a3-mediated inhibition, the gener-
ation of cell culture models as well as of a murine model with a
deleted importin-a3 gene was essential. Our previous observa-
tion that replication of HPAIVs with avian-type polymerases, un-
like HPAIV with human-type polymerases, was restricted in cells
silenced using importin-a3 siRNA and is likely due to residual im-
portin-a3 expression sufficient to induce nuclear import of NF-
kB and thus the transcription of various antiviral genes. Further-
more, our findings here support the concept that avian influenza
viruses evade importin-a3 restriction by blocking its transcrip-
tion. As a consequence, influenza viruses get access to the sec-
ond-most abundant isoform in the lung, importin-a7, to ensure
high-replicative fitness in the human lung (Gabriel et al., 2011).
Finally, we here provide key insights on the dynamic role of the
respiratory importin-a3 protein as an ‘‘immune sensor’’ of viral
infections in the lung. Attempts to restore depleted importin-a3
levels in the lung might pose new strategies to treat severe res-
piratory virus infections.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects
Biopsymaterial from human uninfectedURT (nasal concha) and LRT (lung, mainly consisting of alveolar tissue) was obtained from the
Erasmus Medical Center in Rotterdam, the Netherlands, from donors at the Erasmus Medical Center in Rotterdam. Approval to use
the clinical samples for scientific use was obtained from the Dutch Medical Ethical Committee under the permit numbers #MEC-
2011-129, MEC 2008-207 and MEC 2009-128. Donor sex and age is unknown.
Cells and Viruses
Cell lines of human embryonic kidney cells (HEK293T, ATCC), human alveolar adenocarcinoma cells (A549, H1299, ATCC), african
green monkey kidney cells (VeroE6) and human cervical adenocarcinoma cells (HeLa, ATCC) were grown in Dulbecco’s modified
Eagle’s medium (DMEM, PAA) supplemented with 10% fetal calf serum (FCS; PAA), 1% penicillin/streptomycin (P/S, PAA), and
1% L-Glutamine (PAA). Mouse embryonic fibroblasts (MEF, see description of their generation in a separate paragraph below)
were grown in DMEM supplemented with 10% FCS, 1% P/S, 1% L-Glutamine, 1% sodium pyruvate, and 1% non-essential amino
acids (NEAA, PAA). Immortalized NEMO/MEFs (Makris et al., 2000) were kindly provided byMichael Karin (University of California,
San Diego). Madin Darby canine kidney cells (MDCKII, ATCC) were grown in Minimal Essential Medium (MEM, PAA) supplemented
with 10% FCS, 1% P/S, and 1% L-Glutamine. Primary human bronchial (HBEpC, PromoCell, C-12640) and primary human small
airway epithelial cells (HSAEpC, PromoCell, C-12642) were grown in Airway Epithelial Cell Media or Small Airway Epithelial Cell Media
(PromoCell), respectively, supplemented with 1%P/S. HBEpC cell donor was a 52 year old female subject. HSAEpC cell donor was a
57 year old female subject. Cells were cultivated at 5% CO2, 96% rH and 37
C. Recombinant H7N7 HPAIV viruses SC35-PB2701D,
SC35M-PB2701N, the single-point mutants SC35-PB2701N and SC35-NP319K or the double mutant SC35-PB2701N-NP319K (Gabriel
et al., 2011) as well as recombinant A/Thailand/1(KAN-1)/2004 (H5N1) wild-type strain (H5N1-PB2701N) (Gabriel et al., 2011; Putha-
vathana et al., 2005), the avian-type single point mutant thereof (H5N1-PB2701D) and H7N7 HPAIV virus isolates A/Netherlands/219/
2003 (H7N7-PB2627K, fatal case) or the recombinant virus thereof (H7N7-PB2627E) (Czudai-Matwich et al., 2014; Fouchier et al., 2004)
were used.
All experiments with H5N1 and H7N7 viruses were conducted at the Heinrich Pette Institute, Leibniz Institute for Experimental
Virology in Hamburg, Germany, in biosafety level 3 facilities, except for the SC35M-PB2701N strain that was classified as biosafety
level 2 agent, and approved by the relevant German authorities (Gentechnikbeho¨rde Hamburg).
Animals
Importin-a3/mice in the C57BL/6 genetic background andWT littermates thereof were bred and housed under specific pathogen-
free conditions at the animal facility of the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.We
used 6-12 week old female andmale mice. Experimental groups werematched regarding equal numbers of female andmale mice as
well matched in comparable age groups.
Animal experiments were performed in strict accordance with the guidelines of the German Animal Welfare Regulations. All animal
protocols were approved by the relevant German authority (Beho¨rde f€ur Stadtentwicklung und Umwelt Hamburg, license numbers:
29/09, 54/11). Mice were humanely killed upon > 25%weight loss or upon achievement of defined body index scores (e.g., on phys-
ical appearance, clinical signs, behavior, eating and drinking etc.) according to the German Animal Welfare Regulations.
METHOD DETAILS
Transfection and Vectors
Transfections were performed using Lipofectamine 2000 (Invitrogen) or jetPRIME (Polyplus-Transfection) according to the manu-
facturer’s instructions. Vector constructs used were pHW2000-(SC35-PB2701D, SC35-PB2627K, SC35-PB1, SC35-PA, SC35-NP,
SC35M-PB2701N, SC35M-PB1, SC35M-PA, SC35M-NP) (Gabriel et al., 2005), pcDNA-importin-a1-N-FLAG, pcDNA-importin-a3-
N-FLAG, pcDNA-importin-a5-N-FLAG and pcDNA-importin-a7-N-FLAG, pPol-I-NP-Luc-human (Gabriel et al., 2005), pRL-TK
(Promega), pLightSwitch_Prom-control and pLightSwitch_Prom-importin-a3 (renilla luciferase reporter constructs; SwitchGear Ge-
nomics), pFL-TK and pCMVTAG-NEMO (Addgene). The pcDNA-importin-a-N-FLAG constructs were described previously (Gabriel
et al., 2011; Wang et al., 1997). pFL-TK was generated by amplification of the firefly luciferase gene from the pPol-I-NP-luc-human
construct (Gabriel et al., 2005) using primers p5_NheI_Fluc_for (50-GCGCTAGCCACCATGGAAGACGCCAAAAACATAAAGAA
AGGCCCGGC-30) and p3_Fluc_NotI_rev (50-GCGCGGCCGCTTACAATTTGGACTTTCCGCCCTTCTTGG-30). Insertion of the firefly
luciferase gene into pRL-TK without the renilla luciferase gene was performed via the NheI and NotI restriction sites.
Antibodies
Primary antibodies used for western blot and immunohistochemical analyses include goat anti-importin-a1 (Abcam, ab6036), rabbit
anti-importin-a1 (Abcam, ab54489), goat anti-importin-a3 (Abcam, ab6039), goat anti-importin-a4 (Abcam, ab6038), rabbit anti-im-
portin-a3 (Novus Biologicals, #NB100-93345, replaced by #NB100-81651), rabbit anti-importin-a3 (Ko¨hler et al., 1997), rabbit anti-
importin-a5/a7 (Ko¨hler et al., 1999), rabbit anti-NF-kB p65 (Cell Signaling, #3987), rabbit anti-LSD1 (Cell Signaling, #2139), rabbite2 Cell Reports 31, 107549, April 21, 2020
anti-GAPDH (Cell Signaling, #2118), mouse anti-nuclear matrix protein p84 (Abcam, ab487), mouse anti-FLAG M2 (Sigma-Aldrich,
#F3165), rabbit anti-HA (Sigma-Aldrich, #H908), mouse anti-influenza A virus nucleoprotein (HB65; American Type Culture Collec-
tion, Manassas, VA) antibodies and rabbit anti-FPV serum (Gabriel et al., 2008). Anti-rabbit-HRP, anti-goat-HRP, anti-mouse-HRP
(Sigma-Aldrich, #A8275, #A5420, and #A4416, respectively), and IRDye-conjugated anti-rabbit (Li-Cor) antibodies were used as sec-
ondary antibodies for western blot.
Importin-a sequence analysis
Nucleotide sequences of the coding regions of importin-a1, importin-a3, importin-a4, importin-a5, importin-a6 and importin-a7were
downloaded from the NCBI nucleotide database for Homo sapiens (GenBank: NM_001320611.1, NM_002268.5, NM_002267.4,
CR456743.1, NM_001366307.2, NM_012316.5), Macaca fascicularis (GenBank: NM_001283904.1, XM_005546256.2,
XM_005585866.2, XM_005547987.2, XM_005551660.2, XM_005544119.2), Sus scrofa (GenBank: NM_001163404.1,
XM_021069735.1, NM_001193575.1, NM_001163405.1, XM_005654393.3, XM_021095806.1), Mus musculus (GenBank:
NM_010655.3, NM_008467.4, NM_008466.5, BC006771.1, NM_008468.4), Gallus gallus (GenBank: NM_001006209.1,
NM_001007963.1, NM_001193575.1, NM_001030774.1, XM_015284586.2, NM_001012841.2) and Anas platyrhynchos (GenBank:
XM_005012314.3, XM_027464723.1, XM_027471420.1, XM_027449713.1, XM_027454663.1). For Mus musculus, no importin-a6
sequence was available, while the importin-a7 sequence was missing for Anas platyrhynchos. The nucleotide sequences were sub-
sequently translated into amino acid sequences using the standard genetic code. For each Importin-a, the sequences were aligned
usingMuscle version 3.8.1551 (Edgar, 2004) with standard parameters. Pairwise nucleotide and amino acid sequence identities were
then calculated using Clustal Omega version 1.2.4 (Sievers et al., 2011).
Generation of Importin-a3/ Mice and Importin-a/-MEFs
To generate an importin-a3 targeting construct, a 900 bp-long sequence upstream and a 5100 bp-long sequence downstream of
exon 1 of the importin-a3 gene were cloned into a targeting vector described before (Walther et al., 1998). After homologous recom-
bination in embryonic stem (ES) cells, exon 1 bearing the translational start site for the importin-a3 protein, was deleted. ES cells were
electroporated with the linearized construct and clones were picked after double selection with neomycin and gancyclovir. Positive
clones were identified by PCR and one of them was chosen for blastocyst injection. From the injected ES cell clone, germline chi-
meras were obtained and bred with C57BL/6 mice. Importin-a3 deficient mice were backcrossed for eight generations to the
C57BL/6 genetic background; the colony was maintained by breeding heterozygous mice. For genotyping, the following primers
were used for PCR on genomic DNA of tail or ear biopsies: Impa3for 5’-CCCTCAGTGTGAATTACTTCC-3’; Impa3rev 5’-GAGTC
CAAAGCCACTTCGAG-3’; Impa4neorev 5’-GCCCAGTCATAGCCGAATAG-3’. To confirm the gene deletion, absence of importin-
a3 mRNA and protein was determined by RT-PCR and western blot of organs. Absence of importin-a3 mRNA with b-Actin as
reference was verified using the following primers: Impa3Ex1_for 50-GACAACGAGAAATTGGACAACC-30; Impa3Ex7_rev
50-CGTTCCAGATGCAATGTTTGTC-30; beta-actin_for 50-TACAATGAGCTGCGTGTG-30; beta-Actin_rev 50-CACAGCCTGGATGGC
TAC-30. Wild-type (WT) and importin-a/ murine embryonic fibroblasts (MEFs) were prepared from murine embryos harvested
on embryonic day 13.5 from pregnant females. To obtain immortalized cell lines, primary MEFs were passaged at least 25 times
according to an adaption of the 3T3 protocol (Todaro and Green, 1963).
Generation of Importin-a3/ Cell Lines
To generate H1299 importin-a3/ and control importin-a3+/+ cell lines, the cells were seeded in 12 wells and transfected using Lip-
ofectamine 2000 (Invitrogen) with either a control CRISPR-Cas9 plasmid or an importin-a3/ CRISPR-Cas9 plasmid (Santa Cruz
Biotechnology). 48 hours post transfection positive cells were sorted via FACS into 96 well plates with help of a green fluorescent
protein selection marker. Clones were tested via western blot for importin-a3 expression and positive clones were cultivated further
for cryopreservation.
Animal Experiments
Mice were anaesthetized with ketamine-xylazine (70 mg/kg and 7 mg/kg, respectively) and intranasally infected with the respective
virus dose in 50 ml 1x PBS. WT mice were infected with 6*104 p.f.u. (100-fold MLD50 of SC35M-PB2701N in BALB/c mice
9) of SC35-
PB2701D, SC35M-PB2701N, the single-point mutants SC35-PB2701N or SC35-NP319K or the double mutant SC35-PB2701N-NP319K.
Control groups received PBS. On day 3 p.i., five animals per time point were anaesthetized with an overdose of ketamine-xylazine
(140mg/kg and 14mg/kg, respectively) and sacrificed after intracardial perfusion with DEPC-treated 1x PBS. Perfused organs (lung,
trachea, liver, spleen, brain) were removed and dissected into pieces (< 5mm) and submerged in RNAlaterRNAStabilization Reagent
(QIAGEN). Murine URT samples were obtained by decapitation of the head above the atlas. After skinning and sagittal division of the
head, the tissue of the nasal concha was excised and submerged in RNAlater.
For relative mRNA-Expression levels determination of antiviral genes under an NF-kB promoter by RT-qPCR, WT (n = 5) and im-
portin-a3/ (n = 5) micewere infectedwith 106 p.f.u. of SC35M. Control groups received PBS. On day 3 p.i., five animals were anaes-
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in RNAlater. Organs (lung, spleen, brain) of uninfected WT mice (n = 3) for western blot lysate preparation were obtained after short
inhalative isoflurane narcosis followed by cervical dislocation. After dissection into small pieces, the organs were immediately frozen
on dry ice.
For virus titer determination of organs, WT (n = 3) and importin-a3/ (n = 3) mice were infected with 6*104 p.f.u. of SC35-PB2701D
(~0,1x MLD50 of SC35-PB2701D in C57BL/6 mice) or a low and high dose of SC35M-PB2701N (10
3 p.f.u.; ~0,5x MLD50 or 6*10
4 p.f.u.;
~30x MLD50 of SC35M-PB2701N, respectively). On days 3 and 6 p.i., three animals per time point were sacrificed, organs (lung,
trachea, brain) removed, virus titers determined by plaque assay 64, and the URT and LRT stained immunohistochemically against
influenza virus and importin-a antigen. For this, murine formalin-fixed, paraffin-embedded (FFPE) lungs or skinned, decalcified
FFPE heads were thin sectioned (3 mm). Heads were decalcified in 10% EDTA (pH 7,4) for 8 days, followed by sagittal division
and incubation in same solution for 3 more days. Mouse lethal dose 50 (MLD50) was assessed by infecting WT (n = 4-9) and impor-
tin-a3/ (n = 4-9) mice with serial virus dilutions of SC35-PB2701D (10
5, 5*105, and 106 p.f.u.) or SC35M-PB2701N (10
2, 103, and 104
p.f.u.). Animals were monitored for weight and survival for 14 days p.i. and the MLD50 was calculated. Humane endpoints were
defined according to the German Animal Welfare Regulations as described above.
Immunohistochemical Analysis (IHC-P)
Viral and importin-a1, -a3, and -a7 antigen were determined by IHC-P with antigen-specific primary and HRP-conjugated secondary
antibodies. URT and lungs of infected WT and importin-a3/ mice were excised on days 1 and 3 p.i.. FFPE thin-sections (3 mm) of
murine samples and human biopsies were prepared as described (Gabriel et al., 2009). Viral antigen was stained using the mouse
anti-influenza A nucleoprotein (HB65; American Type Culture Collection, Manassas, VA) or the rabbit anti-FPV-serum, a biotin-con-
jugated anti-rabbit secondary antibody (Jackson ImmunoResearch, #711-066-152), the Avidin/Biotin Blocking Kit SP2001 (Biozol),
and the ZytoChemPlus (HRP) Broad Spectrum (DAB) Kit (Zytomed) according to the manufacturer’s instructions. For visualization of
importin-a isoforms in murine and human FFPE samples, the described rabbit anti-importin-a1, rabbit anti-importin-a3 (Novus
Biologicals), and rabbit anti-importin-a5/a7 antibodies were used together with a biotin-conjugated anti-rabbit secondary antibody
(DAKO; #E0432), a peroxidase-conjugated avidin-biotin-complex-reaction kit (DAKO), and the HRP substrate AEC (DAKO). Counter-
staining was performed with hematoxylin. Since the importin-a7 antibody, cross-reacts with importin-a5, lung tissues of mice with a
deletion of either the importin-a5 or the -a7 gene were additionally used as controls (data not shown). To exclude false-positive stain-
ing due to cross-reactivity of the antibodies, FFPE thin sections were additionally stained using importin-a isoform-specific blocking
peptides for importin-a1 (aa518-529, QVQDGAPGTFNF, GenScript), importin-a3 (aa509-521, NSSANVPTEGFQF, Abcam,
#ab23144), importin-a5 (aa3-16, TPGKENFRLKSYKN, GenScript) and importin-a7 (aa3-12, MASPGKDNYR; aa526-536, PEAP-
MEGFQL, GenScript) in different concentrations (0.2 mg/ml, 2 mg/ml, and 20 mg/ml) (Table S5). Primary antibodies were incubated
with the respective peptides for 30 min prior to IHC-P. No unspecific staining was observed with 2 mg/ml and 20 mg/ml of peptide
(data not shown). Images were acquired using a NIKON AZ100 wide field light microscope with a NIKON DS-Ri1 high-resolution mi-
croscope camera, AZ Plan Fluor 5x and AZ Plan Apo 1x objectives, and the NIKON Digital Sight DS-L2 Imaging Controller. Image
processing was performed using Adobe Photoshop CS4 Extended v.11.0.2.
Laser Microbeam Microdissection (LMM)
LMM was performed on murine lung cryosections to obtain bronchiolar epithelium and alveolar tissue samples using the PALM
MicroBeam System (Axiovert 200 microscope incl. PALM CapMover, PALM RoboStage I, PALM RoboSoftware v2.2.; P.A.L.M.
Microlaser Technologies GmbH/ZEISS). After thoracotomy of WT C57BL/6 mice, lungs were filled with Tissue Tek Compound
(50% in 1x PBS, Sakura Finetek) and were shock-frozen in melting isopentane. Cryosections (10 mm) were generated at the Cryostat
CM3050 S (LEICA), let dry for 5 min at 20C and stained with cresyl violet (2 min 70% ethanol, 20C; 2 s 1% cresyl violet in 50%
ethanol, RT; 30 s 70% ethanol, 20C; 30 s 100% ethanol).
RNA Isolation
Total RNA from cells or tissue samples was isolated using the innuprep RNA Minikit (Analytik Jena). Homogenization of ~50 mg of
RNAlater-fixed organs was performed in 450 ml lysis buffer RL with 10 sterile, stainless steel beads (Ø 2 mm, #22.455.0010, Retsch)
at 30 Hz and 4C for 6 min in the mixer mill MM400 (Retsch). RNase free DNase Set (QIAGEN) was used for on-column DNase I-treat-
ment. After elution in RNase-free water, 1 U/mlRibolock RNase Inhibitor (Thermo Scientific) was added. RNA concentration and purity
were determined using the Nanodrop 1000 (Peqlab). Microdissected murine tissue was vortexed for 1 min in lysis buffer RL, incu-
bated for 30 min at RT and vortexed again (1 min). After short centrifugation, the lysate was stored at80C overnight. After thawing,
1min of vortexing, and centrifuging (8 s), the sample wasmixed ten times with 700 ml of 70% ethanol using a needle and syringe. RNA
was isolated according to the innuprep RNA Minikit’s instructions. Total RNA from human FFPE URT was isolated from 1-2 sections
(20 mM) after xylene deparaffinization using the QIAGEN RNeasy FFPE Kit (QIAGEN). Isolated RNA was either processed
immediately or stored at 80C.
cDNA Generation
cDNA from tissues or cells was generated using random primers and the SuperScript III Reverse Transcriptase (Invitrogen) according
to the manufacturer’s instructions. Random nonamer primer (Gene Link, pd(N)9, 26-4000-06, final concentration: 5 mM) and dNTPe4 Cell Reports 31, 107549, April 21, 2020
mix (QIAGEN, final concentration: 500 mMeach dNTP) were incubated for 5min at 65Cwith 5 mg of total RNA in a final volume of 13 ml
and cooled for at least 1 min on ice. Then, 1x First Strand Buffer, DTT (final concentration: 5 mM), RiboLock RNase Inhibitor (Thermo
Scientific, final concentration: 2 U/ml), and 10 U/ml SuperScript III Reverse Transcriptase were added (final reaction volume: 20 ml).
cDNA was generated using the GeneAmp PCR System 9700 (Applied Biosystems; cycle: 25C for 5 min, 50C for 60 min, 70C
for 15 min, 4C forN).
cDNA frommicrodissected samples was generated using the RevertAid HMinus Reverse Transcriptase (Thermo Scientific). 2 ml of
total RNA were treated with 1 U/ml DNase I and 1x DNase I buffer (Sigma-Aldrich, #AMPD1) for 15 min at RT (reaction volume: 10 ml).
DNA restriction was stopped by adding 1.5 ml 50 mM EDTA and incubation for 10 min at 70C. Then, 1x Reaction Buffer, DTT (final
concentration: 500 mM), dNTP-Mix (Peqlab; final concentration: 500 mM each dNTP), 250 ng random hexamer primer (pd(N)6,
Eurofins MWG Operon), and 100 U RevertAid H Minus Reverse Transcriptase were added (final reaction volume: 20 ml). cDNA
was generated using the cycle 42C for 50 min, 70C for 15 min, and 4C forN.
For cDNA from human FFPE URT, 250 ng of total RNA were incubated with Random Primers (Promega, 500 mg/ml, # C1181; final
concentration: 500 ng) and dNTP mix (final concentration: 500 mM each dNTP) for 5 min at 65C in a volume of 13 ml. After cooling (at
least 1 min on ice), 1x First Strand Buffer, DTT (final concentration: 5 mM), RNasin Ribonuclease Inhibitor (Promega, #N251B; final
concentration: 2 U/ml) and 10 U/ml SuperScript III Reverse Transcriptase were added (final reaction volume: 20 ml). cDNA was gener-
ated using the following cycle: 25C for 5 min, 50C for 45 min, 70C for 15 min, and 4C forN. All cDNA samples were processed
immediately or stored at 20C.
Design of RT-qPCR Primers
DNA oligonucleotides (Sigma-Aldrich; Table S6 for RT-qPCR were designed using Clone Manager 9 Professional Edition or Primer-
BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi).
Real-Time Quantitative PCR (RT-qPCR)
Gene of interest (GoI) mRNA expression levels were determined using specific primer pairs (Table S6). Singleplex reactions (10 ml)
were set up manually in UltraPure DNase/RNase-Free Distilled Water (GIBCO) in MicroAmp Optical 96-Well Reaction Plates (Invi-
trogen, #4306737): 5 ml Platinum SYBR Green qPCR SuperMix-UDG (2x, Invitrogen), 0.02 ml ROX Reference Dye (25 mM, Invitro-
gen, final concentration: 50 nM), 300 nMof forward and reverse primer each, and 1 ml cDNA template. RT-qPCR runswere conducted
on the ABI 7500 Fast System (Applied Biosystems) in the Standard 7500 mode with endpoint fluorescence detection: 2 min at 50C,
3 min at 95C, 50 amplification cycles (15 s at 95C, 10 s at 65C, and 30 s at 72C). Analysis was performed in triplicate or quadru-
plicate for each GOI and GAPDH in each sample. Subsequently, melting curve analysis was performed on the ABI 7500 Fast System
(15 s at 95C, 1min at 60C, 15 s at 95C). Correct amplicon size was checked by agarose gel electrophoresis. Data of reactions with
false products was excluded from data analyses. Relative expression values were determined using the E-DDCT-method (Ramakers
et al., 2003; Ruijter et al., 2009). The Rn-values were exported from the SDS Software v1.3.1 (Applied Biosystems) toMicrosoft Office
Excel 2007 and N0-values for the starting concentration of the transcript in the original sample were obtained with LinReg PCR Soft-
ware v11.1 (Ruijter et al., 2009). The averaged N0-value of the GOI (e.g., N0 (importin-a3), n = 3–4 technical replicates) was then normal-
ized with the averaged N0-value for GAPDH (N0 (GAPDH)) of the respective sample. The relative N0(GOI)/N0 (GAPDH)-expression values of
the biological replicates are presented. For easier comparison of differential expression, the averaged relative N0-value was set 1.
Relative mRNA expression levels of NF-kB regulated genes were determined using specific primer pairs (Table S6) for the genes
of interest (GOIs) and the reference gene HPRT. Singleplex reactions (20 ml) were set up manually in H2O PCR grade (ROCHE)
in LightCycler 480 Multiwell Plate 96 (ROCHE, #04729692001): 10 ml FastStart Essential DNA Green Master (2x, ROCHE),
300 nM of forward and reverse primer each, and 2 ml cDNA template. RT-qPCR runs were conducted on the LightCycler 96
Real-Time PCR System (ROCHE) with endpoint fluorescence detection: 10 min at 95C, 50 amplification cycles (15 s at 95C,
10 s at 65C, and 20 s at 72C). Analysis was performed in triplicate for each GOI and HPRT in each sample. Subsequently, melting
curve analysis was performed (15 s at 95C, 15 s at 60C, 1 s at 95C). Correct amplicon size was checked by agarose gel electro-
phoresis. The relative N0(GOI)/N0 (HPRT)-expression values of the biological replicates are presented.
Protein Extraction and Purification
Whole cell lysates (WCL) of cells were obtained by lysis in HEPES lysis buffer (50 mM HEPES (pH 8.0), 200 mM NaCl, 0.5% IGEPAL,
25% glycerol, 1 mM PMSF, 0,07 ml/ml b-mercaptoethanol, 1x HALT Protease and Phosphatase Inhibitor Cocktail, 1x EDTA Solution)
or samples were fractionated into cytoplasmic (CF) and nuclear fractions (NF) using the NE-PERNuclear and Cytoplasmic Extraction
Reagents (Thermo Fisher Scientific Inc.). Whole organ lysates of uninfectedWTmicewere obtained byweighing ~30mg of tissue into
O-ring tubes filled with 8 stainless steel beads (Ø 2 mm, #22.455.0010, Retsch). After washing the organ pieces once with 800 ml 1x
PBS and centrifugation at 500 xg and 4C for 5 min, the supernatant was discarded and 10 ml HEPES lysis buffer per mg organ were
added. Homogenization was carried out at 4C and 20 Hz for 2 min followed by 30 Hz for 1 min in the mixer mill MM400 (Retsch). The
homogenates were then incubated for 5 min on ice and subsequently centrifuged for 20 min at 21,000 xg and 4C. The supernatant
was transferred into a fresh tube, mixed with 4x protein loading dye and boiled for 5 min at 95C before being subjected to western
blot analysis. Whole cell lysates of HEK293T cells transfected with 10 mg of each of the pcDNA-importin-a-N-FLAG constructs were
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(Sigma-Aldrich) according to the manufacturer’s instructions. Thus, purified FLAG-tagged importin-a isoforms were obtained and
used to generate standard curves to determine the affinities of the different isoform-specific importin-a antibodies. The protein
amounts of each isoform were quantified in murine organ homogenates using western blot analyses and standardized using the in-
dividual standard curves as described previously (Ko¨hler et al., 2002, 1999).
Western Blot
Successful knockdown of importin-a isoforms was confirmed by western blot analysis using the described goat anti-importin-a1,
goat anti-importin-a3, goat anti-importin-a4, and rabbit anti-importin-a5/a7 antibodies, respectively, with normalization to GAPDH
using the rabbit anti-GAPDH antibody. The same antibodies were used for detection and quantification of endogenous importin-a
isoforms in cell or organ lysates. For detection and quantification of FLAG-tagged importin-a isoforms, themouse anti-FLAGM2 anti-
body was used. Amounts of viral NP protein or NF-kB p65 in cell lysates after viral infection or TNF-a treatment were quantified using
the rabbit anti-FPV serum and the rabbit anti-NF-kB p65 antibodies, respectively. For detection of HA-tagged NEMO, the rabbit anti-
HA antibody was used. Equal amount of protein was loaded for each sample using GAPDH, p84 or LSD1 as loading control. Quan-
tification of protein was performed with the Bioimager Image Quant LAS 4000 at non-saturated levels with GAPDH or LSD1 adjust-
ment for WCL, GAPDH adjustment for CF, and LSD1 of p84 adjustment for NF. Alternatively, NP levels were adjusted and used for
normalization.
Immunofluorescence
WT MEFs as well as MEFs deficient for importin-a3 were seeded in glass bottom dishes (#81218-200, Ibidi GmbH) using regular
growth medium (10% FBS, 1% P/S, 1% L-Glutamine, 1% NEAA, 1% sodium pyruvate). After 8h, the growth medium was replaced
with starvationmedium (serum reduced to 0.5%FBS) and cells were starved for another 16h. Subsequently, cells were either control-
treated or treated with murine TNF (10 ng/ml; #575204, BioLegend, Inc) for 15 min at 37C. Then, immunofluorescence staining was
performed. All washing stepswere performedwith phosphate buffered saline (PBS), and all incubation steps were performed at room
temperature, if not otherwise stated. Briefly, cells were washed and fixed with 4% paraformaldehyde (in PBS) for 10 min at 37C.
Fixed cells were washed twice and permeabilized with 0.1% Triton X-100 (in PBS) for 20 min. After washing, cells were blocked
with 3% bovine serum albumin (BSA) solution (in PBS) and then incubated with a primary antibody recognizing murine NF-kB p65
subunit (1:300 in 3%BSA/PBS; #8242S, Cell Signaling) for 1h. Cells were washed again and incubated for 1h with a donkey anti-rab-
bit IgG antibody coupled to Alexa-555 dye (1:500 in 3% BSA/PBS; A31572, Life Technologies GmbH). This step also included stain-
ing of nuclei with Hoechst dye (1:1000 in 3% BSA/PBS; #62249, Life Technologies GmbH). After further washing, stained cells were
stored in PBS at 4C. Images were acquired on a confocal Nikon Eclipse Ti-E spinning disc microscope (Nikon, Japan) at 100-fold
magnification. Image processing was performed using Nikon NIS-Elements Advanced Research (version 4.51; Nikon, Japan) and
ImageJ software (National Institute of Health, NIH). Semi-automatic quantification of nuclear and cytoplasmic NF-kB p65 signals
was carried out using a custom-designed plugin for the ImageJ software which is available on request. Data are based on three in-
dependent biological replicates, each performed with technical duplicates.
HPAIV Growth Kinetics
WT MEFs and MEFs with deleted importin-a3 or -a7 genes were infected with different multiplicities of infection (MOI) of SC35-
PB2701D (H7N7, MOI 1 or 0.1) or SC35M-PB2701N virus (H7N7, MOI 0.01 or 0.001). 7*10
5 cells were inoculated with 2mL virus dilution
in DMEM (containing 1% P/S, 1% L-Glutamine, 1% NEAA, 1% sodium pyruvate) and incubated for 30 min at 5% CO2, 96% rH and
37C. After washing twice with acidic incubation medium (DMEM, pH 5.0, containing 1% FCS, 1% P/S, 1% L-Glutamine, 1%NEAA,
1% sodium pyruvate), 2 mL of pH-neutral incubation medium were added and the infected cells were incubated at 37C. Virus titers
of supernatants taken at 0, 24, 48, 72, and 96 hours post infection (p.i.) were determined as plaque forming units per ml (p.f.u./ml) by
plaque assay 17 on MDCKII. For determination of importin-a protein levels after viral infection, WT MEFs were infected with SC35-
PB2701D or SC35M-PB2701N virus at an MOI of 0.1. of WT MEF. Similarly, H1299 WT and H1299 with deleted importin-a3 gene
were treated with TNFa (10ng/ml) 24h prior to inoculated with SC35M-PB2701N at MOI 0.001 (see above). TNFa treatment was re-
applied and supernatant taken at 0, 24 and 48h p.i. Virus titers were determined by plaque assay on MDCK cells and given in
p.f.u/ml. Additionally, primary human lung cells (HBEpC and HSAEpC) were infected with H5N1-PB2701N and H5N1-PB2701D
(MOI = 0.1 and 1) or H7N7-PB2627K and H7N7-PB2627E (MOI = 1 and 10). Cells were lysed 24 and/or 48 hours p.i. in lysis buffer
(50 mM HEPES (pH 8.0), 200 mM NaCl, 0.5% IGEPAL, 25% glycerol (Invitrogen), 1 mM PMSF, 0,07 ml/ml b-mercaptoethanol, 1x
HALT Protease and Phosphatase Inhibitor Cocktail, 1x EDTA Solution (both: 100x, Pierce/Thermo Scientific). Whole cell protein ex-
tracts were subjected to western blot analysis.
Library Preparation and Next Generation Sequencing
Lungs of WT and a3/ mice infected with 6*104 p.f.u. of SC35-PB2701D or SC35M-PB2701N (H7N7) were subjected to gene expres-
sion analysis. Control mice received PBS. On day 3 p.i., whole lungs were perfused, harvested and submerged in RNAlater and total
RNA was isolated using the innuprep RNAMini Kit (Analytik Jena). RNA samples from three animals per mouse strain and virus were
pooled and used for gene expression analysis. For each sample, 1mg of total RNA was used for generating sequencing libraries
with the Illumina TruSeq RNA Sample Preparation Kit v2 as recommended by the manufacturer (Illumina Inc.). Size and quality ofe6 Cell Reports 31, 107549, April 21, 2020
the libraries were visualized on a BioAnalyzer High Sensitivity DNA Chip (High Sensitivity DNA Kit, Agilent Technologies). Diluted li-
braries (2 nM) weremultiplex-sequenced on the Illumina HiSeq 2500 instrument. For each sample between 78 and 113M, paired-end
reads of 101 bp length were generated. The reads were aligned to the murine reference transcriptome (UCSC mm10) using Bowtie2
(v2.2.2) (Langmead and Salzberg, 2012). DESeq (Anders and Huber, 2010) was employed to assess differential expression based on
read counts per gene. Genes were hierarchically clustered according to their expression profiles using the R function hclust (http://
www.R-project.org/). DAVID (v6.7) (Huang et al., 2009) was employed to functionally annotate the resulting clusters. Networks of pro-
tein-protein interactions were computed and visualized using Cytoscape (Shannon et al., 2003).
TNF-a ELISA
TNF-a protein amount was determined in lung homogenate supernatants of WT mice infected intranasally with 6*104 p.f.u. of SC35-
PB2701D or SC35M-PB2701N viruses (H7N7). Whole lungs were harvested on day 1 p.i. and ~50–100 mg of tissue homogenized with
~300 ml glass beads (RETSCH #22.222.0003) in 1mL 1x PBS (PAA) in themixer mill MM400 (Retsch; 20 Hz, 4C, 10min). After centri-
fugation (6000 xg, 4C, 5 min), lung homogenate supernatants were stored at 80C. Supernatants of three animals per virus were
pooled. Then, the Enzyme-linked Immunosorbent Assay (ELISA) Kit for murine TNF-a was performed according to the manufac-
turer’s instructions (#E90133Mu, USCN Life Science Inc.).
TNF-a Treatment, Importin-a3 mRNA Expression, Subcellular Localization and Promoter Activation
HSAEpC, WT MEFs and NEMO/ MEFs were seeded in 24-well plates until confluent or in 10 cm-dishes for 24 h, respectively, and
serum starved for 24 h. Then, cells were control-treated (w/o) or treated with human TNF-a (50 ng/ml; #210-TA, R&D Systems) for 6 h
or with murine TNF-a (50 ng/ml; #575204, BioLegend, Inc.) for 6 h or 24 h, respectively. WCL, CF, and NF were subjected to western
blot analysis for importin-a3 andNF-kBp65 detection. Total RNAwere isolated 6h post treatment for relative importin-a3 expression,
using RT-qPCR.
For determination of the relative importin-a3 mRNA expression levels after cytokine treatment, NEMO/ MEFs were seeded in
10cm cell culture dishes (5x106 cells per dish). After serum starvation for 24 h, cells were control-treated (mock) or treated 10 min
with 10ng/ml of murine TNF-a, IL-6, IL-10, IFN-g and TGF-b. After 6h post treatment, cells were harvested, RNA isolated and
cDNA generated before RT-qPCR analysis.
For the determination of nuclear import of NF-kB p65 after TNF-a stimulation, WT MEF and Importin a3 KO MEF were seeded in
10cm cell culture dishes (1x106 cells per dish). After serum starvation for 18 h, cells were treated with 10ng/ml TNF-a. Subsequently,
cells were harvested by scraping in ice-cold PBS, centrifuged and after removing the supernatant, the cells were resuspended in 50ml
of Buffer A (10mM Tris pH7,9; 1,5mMMgCl2; 10mM KCl). After adding 6ml of 2% NP-40 and vortexing, the samples were incubated
for 10min on ice and centrifuged f€ur 15min at 6,0000rpm at 4C. The supernatant (cytosolic fraction) was placed in a fresh tube, sub-
sequently the pellet was washed again with 100ml of buffer A, centrifuged again for 15min and the supernatant was removed. For
nuclear fractions, the pellet was resuspended in 50 ml of buffer B (20 mM Tris pH 7.9; 10mM KCl; 1.5mM MgCl2; 20% Glycerol)
and vortexed; then 33 ml of buffer C (20mM Tris pH 7.9; 1.2M KCl; 1.5 mM MgCl2; 20% Glycerol) was added and the samples
were incubated on a wheel at 4C for 45 min. Afterward, samples were centrifuged for 30 min at 12,000 rpm at 4C and the super-
natant (nuclear fraction) was transferred to a fresh reaction tube. Both fractions were mixed with 4x protein loading dye and boiled for
5 min at 95C before being subjected to western blot analysis.
For determination of importin-a3 promoter activation in MEF cells, cells were seeded in 96-well plates (5000 cells/well) to reach
approximately 60% confluency after 24h. Then, cells were transfected using FuGene HD transfection reagent (SwitchGear Geno-
mics), either with pLightSwitch-Prom-Control (SwitchGear Genomics; 100 ng/well) as a control, or pLightSwitch-Prom-importin-
a3 (SwitchGear Genomics; 100 ng/well) for importin-a3 promoter activity readout. After 24h, transfected cells were treated with mu-
rine TNF-a, IL-10 or TGF-b at 0, 1 or 50 ng/ml, for 15 min. Promoter activity was measured at 3h post treatment using LightSwitchTM
Luciferase Assay Reagent (SwitchGear Genomics, LS010) according to manufacturer’s instructions.
For determination of importin-a3 promoter activation, A549 or HSAEpC were seeded in 96-well plates for 24 h or until 80% con-
fluency, respectively, and transfected with pLightSwitch_Prom-control (50 ng; Control) or pLightSwitch_Prom-importin-a3 (50 ng;
a3) and pFL-TK (250 ng; firefly luciferase transfection control) using Lipofectamine-2000 or jetPRIME, respectively. 14 h after
transfection, serum starvation was initiated for 30 h. Subsequently, cells were treated with 0, 10, 50 or 100 ng/ml (A549) or with 0,
1, 10 or 100 ng/ml (HSAEpC) of human TNF-a and lysed 20 h later. Firefly and Renilla luciferase activities were assessed using
the Dual-Luciferase Reporter Assay System (Promega, E1910).
NEMO Complementation Assay
NEMO/MEFswere transfected in suspensionwith 5 mg empty vector pcDNA3.1 or pcDNA-HA-humanNEMO in 6-well plates using
Lipofectamine 2000 (Invitrogen) for 6 h. At 48 h post transfection, cells were serum starved for 24 h. Then, cells were control-treated
(w/o) or treated with murine TNF-a (50 ng/ml; #575204, BioLegend, Inc.) for 6 h. WCL were subjected to western blot analysis for
importin-a3 and NEMO detection.Cell Reports 31, 107549, April 21, 2020 e7
QUANTIFICATION AND STATISTICAL ANALYSIS
P values of RT-qPCR data were obtained by Kruskal-Wallis one-way ANOVA using PAST v.2.17c (http://folk.uio.no/ohammer/past/).
RT-qPCR data were considered as relevant when more than ± 1.5-fold change was detected in relative mRNA expression levels.
Statistical significance of animal survival rates was determined with GraphPad Prism 5 v.5.03 (Graphpad Software, Inc.) using the
Log Rank (Mantel-Cox) test and the Kaplan-Meier survival curves. All other mean values, standard deviations (SD), and P values
were calculated with GraphPad Prism 5 (v5.03) or the GraphPad Software, Inc. tool (https://www.graphpad.com/quickcalcs/
ttest1/?Format=SD) using the unpaired, two-tailed Student’s t test or the one-sample, two-tailed Student’s t test when all values
in one group were identical, e.g., set 100%. Statistical significance was defined as p < 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001).
DATA AND CODE AVAILABILITY
Transcriptome sequence data reported in this publication is submitted to the European Nucleotide Archive (ENA) and is available
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